The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...
The Safer Drugs Consumption Facility in Glasgow opened on 13 January, letting people take substances under supervision. The proposed value of its new contract is £4.8m - about £300,000 lower ...
"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...